Liu Yihua, Mahara Atsushi, Kambe Yusuke, Hsu Yu-I, Yamaoka Tetsuji
Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Biomater Sci. 2021 Feb 9;9(3):1034-1043. doi: 10.1039/d0bm01396j.
Blood compatibility generally requires two contradictory characteristics: reduced protein/platelet adhesion and excellent endothelium-related cell affinity. To understand the effect of cell adhesion peptides on blood compatibility, the peptides REDV, RGD, and hemocompatible peptide-1 (HCP-1) were immobilized on an expanded polytetrafluorethylene (ePTFE) surface and evaluated in vitro, in situ, and in vivo. Since the terminal amino groups of functional peptides often have an important effect, a cysteine residue was added to the C terminal and used for immobilization to keep the terminal amino groups free. Maleimide groups were added to carboxylic groups of highly hydrophilic and biologically inert (bioinert) polymer chains grafted onto ePTFE and coupled with cysteine residues. In vitro tests revealed that free N-terminal HCP-1 and RGD-immobilized surfaces improved the adhesion and spread of human umbilical vein endothelial cells (HUVECs), while, unexpectedly, a free N-terminal adjacent to REDV suppressed cell affinity. In situ evaluation with a porcine closed-circuit system for 2 h showed that no platelets adhered to the modified ePTFE sutures due to the bioinert graft chain containing phosphorylcholine groups. Simultaneously, leukocyte-related and endothelium-related cells were observed on RGD-immobilized ePTFE sutures because RGD was recognized by broad types of cells. These cells were not observed on the HCP-1- and REDV-immobilized ePTFE sutures, which may be due to insufficient exposure time. HCP-1-modified ePTFE graft implantation in a porcine femorofemoral (FF) bypass model for 10 days showed that the thrombus layer was clearly mitigated by HCP-1 immobilization. This study suggests that the HCP-1-immobilized ePTFE surface has potential for long-term application by mitigating thrombus and supporting endothelial cell adhesion.
降低蛋白质/血小板粘附性和具有出色的内皮相关细胞亲和力。为了解细胞粘附肽对血液相容性的影响,将肽REDV、RGD和血液相容性肽-1(HCP-1)固定在膨体聚四氟乙烯(ePTFE)表面,并进行体外、原位和体内评估。由于功能性肽的末端氨基通常具有重要作用,因此在C末端添加了一个半胱氨酸残基用于固定,以使末端氨基保持游离状态。将马来酰亚胺基团添加到接枝到ePTFE上的高度亲水且生物惰性的聚合物链的羧基上,并与半胱氨酸残基偶联。体外测试表明,游离N末端的HCP-1和固定有RGD的表面改善了人脐静脉内皮细胞(HUVEC)的粘附和铺展,而出乎意料的是,与REDV相邻的游离N末端抑制了细胞亲和力。在猪闭路系统中进行2小时的原位评估表明,由于含磷酰胆碱基团的生物惰性接枝链,没有血小板粘附在改性的ePTFE缝合线上。同时,在固定有RGD的ePTFE缝合线上观察到了白细胞相关细胞和内皮相关细胞,因为RGD被多种类型的细胞识别。在固定有HCP-1和REDV的ePTFE缝合线上未观察到这些细胞,这可能是由于暴露时间不足所致。在猪股股(FF)旁路模型中植入HCP-1改性的ePTFE移植物10天表明,通过固定HCP-1可明显减轻血栓层。这项研究表明,固定有HCP-1的ePTFE表面通过减轻血栓形成和支持内皮细胞粘附而具有长期应用的潜力。